Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Broad Institute partners with Roche to repurpose abandoned drugs
Drugmaker Roche will give researchers at the Broad Institute access to 300 compounds with various indications in an effort to identify new targets for the drugs, which failed to meet endpoints or whose development was halted for other reasons. The Broad Institute has reached similar partnership deals with AstraZeneca and Novartis.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .